Tuesday, 30 May 2017
Rohto Pharma invests $5 million in SastaSundar Healthbuddy
NEW DELHI: Japanese firm Rohto Pharmaceutical Co has invested USD 5 million (over Rs 32 crore) to acquire 13 per cent stake in SastaSundar Healthbuddy Ltd. The Indian firm is looking at launching operations in the national capital with plans to expand in 12 states across the country.
You can read more here: Rohto Pharma invests $5 million in SastaSundar Healthbuddy
Subscribe to:
Post Comments (Atom)
Life insurers earn more in Oct selling lesser policies
The 24-company Indian life insurance industry closed last month with new business of Rs 22,776.03 crore, up by 31.87 per cent over the prev...
-
In an interview with ET Now, N Jayakumar, Prime Securities , says as people feel more comfortable about putting in SIP kind of flows into t...
-
India’s logistics industry is undergoing a transformative period. In this article, we discuss the current state of the sector, and how the...
No comments:
Post a Comment